Literature DB >> 22750014

Mechanotransduction in bone tissue: The A214V and G171V mutations in Lrp5 enhance load-induced osteogenesis in a surface-selective manner.

Paul J Niziolek1, Matthew L Warman, Alexander G Robling.   

Abstract

Mechanotransduction in bone requires components of the Wnt signaling pathway to produce structurally adapted bone elements. In particular, the Wnt co-receptor LDL-receptor-related protein 5 (LRP5) appears to be a crucial protein in the mechanotransduction cascades that translate physical tissue deformation into new bone formation. Recently discovered missense mutations in LRP5 are associated with high bone mass (HBM), and the altered function of these proteins provide insight into LRP5 function in many skeletal processes, including mechanotransduction. We further investigated the role of LRP5 in bone cell mechanotransduction by applying mechanical stimulation in vivo to two different mutant mouse lines, which harbor HBM-causing missense mutations in Lrp5. Axial tibia loading was applied to mature male Lrp5 G171V and Lrp5 A214V knock-in mice, and to their wild type controls. Fluorochrome labeling revealed that 3 days of loading resulted in a significantly enhanced periosteal response in the A214V knock in mice, whereas the G171V mice exhibited a lowered osteogenic threshold on the endocortical surface. In summary, our data further highlight the importance of Lrp5 in bone cell mechanotransduction, and indicate that the HBM-causing mutations in Lrp5 can alter the anabolic response to mechanical stimulation in favor of increased bone gain.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750014      PMCID: PMC3784262          DOI: 10.1016/j.bone.2012.05.023

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  32 in total

1.  Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.

Authors:  Xiaolin Tu; Yumie Rhee; Keith W Condon; Nicoletta Bivi; Matthew R Allen; Denise Dwyer; Marina Stolina; Charles H Turner; Alexander G Robling; Lilian I Plotkin; Teresita Bellido
Journal:  Bone       Date:  2011-10-30       Impact factor: 4.398

2.  Mechanotransduction in the cortical bone is most efficient at loading frequencies of 5-10 Hz.

Authors:  S J Warden; C H Turner
Journal:  Bone       Date:  2004-02       Impact factor: 4.398

3.  Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13)

Authors:  M L Johnson; G Gong; W Kimberling; S M Reckér; D B Kimmel; R B Recker
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

4.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

5.  Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.

Authors:  Xiaofeng Li; Yazhou Zhang; Heeseog Kang; Wenzhong Liu; Peng Liu; Jianghong Zhang; Stephen E Harris; Dianqing Wu
Journal:  J Biol Chem       Date:  2005-03-18       Impact factor: 5.157

6.  High bone density due to a mutation in LDL-receptor-related protein 5.

Authors:  Lynn M Boyden; Junhao Mao; Joseph Belsky; Lyle Mitzner; Anita Farhi; Mary A Mitnick; Dianqing Wu; Karl Insogna; Richard P Lifton
Journal:  N Engl J Med       Date:  2002-05-16       Impact factor: 91.245

7.  Improved bone structure and strength after long-term mechanical loading is greatest if loading is separated into short bouts.

Authors:  Alexander G Robling; Felicia M Hinant; David B Burr; Charles H Turner
Journal:  J Bone Miner Res       Date:  2002-08       Impact factor: 6.741

8.  Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.

Authors:  Liesbeth Van Wesenbeeck; Erna Cleiren; Jeppe Gram; Rodney K Beals; Olivier Bénichou; Domenico Scopelliti; Lyndon Key; Tara Renton; Cindy Bartels; Yaoqin Gong; Matthew L Warman; Marie-Christine De Vernejoul; Jens Bollerslev; Wim Van Hul
Journal:  Am J Hum Genet       Date:  2003-02-10       Impact factor: 11.025

9.  Bone biomechanical properties in LRP5 mutant mice.

Authors:  M P Akhter; D J Wells; S J Short; D M Cullen; M L Johnson; G R Haynatzki; P Babij; K M Allen; P J Yaworsky; F Bex; R R Recker
Journal:  Bone       Date:  2004-07       Impact factor: 4.398

10.  High bone mass in mice expressing a mutant LRP5 gene.

Authors:  Philip Babij; Weiguang Zhao; Clayton Small; Yogendra Kharode; Paul J Yaworsky; Mary L Bouxsein; Padmalatha S Reddy; Peter V N Bodine; John A Robinson; Bheem Bhat; James Marzolf; Robert A Moran; Frederick Bex
Journal:  J Bone Miner Res       Date:  2003-06       Impact factor: 6.741

View more
  26 in total

Review 1.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 2.  Low-Density Lipoprotein Receptor-Related Proteins in Skeletal Development and Disease.

Authors:  Tao Yang; Bart O Williams
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 3.  LRP receptor family member associated bone disease.

Authors:  N Lara-Castillo; M L Johnson
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

4.  Mechanical loading disrupts osteocyte plasma membranes which initiates mechanosensation events in bone.

Authors:  Kanglun Yu; David P Sellman; Anoosh Bahraini; Mackenzie L Hagan; Ahmed Elsherbini; Kayce T Vanpelt; Peyton L Marshall; Mark W Hamrick; Anna McNeil; Paul L McNeil; Meghan E McGee-Lawrence
Journal:  J Orthop Res       Date:  2017-08-11       Impact factor: 3.494

Review 5.  Exploiting the WNT Signaling Pathway for Clinical Purposes.

Authors:  Mark L Johnson; Robert R Recker
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

Review 6.  Regulation of Wnt/β-catenin signaling within and from osteocytes.

Authors:  Travis A Burgers; Bart O Williams
Journal:  Bone       Date:  2013-03-05       Impact factor: 4.398

Review 7.  Mechanosignaling in bone health, trauma and inflammation.

Authors:  Derrick M Knapik; Priyangi Perera; Jin Nam; Alisa D Blazek; Björn Rath; Binnaz Leblebicioglu; Hiranmoy Das; Lai Chu Wu; Timothy E Hewett; Suresh K Agarwal; Alexander G Robling; David C Flanigan; Beth S Lee; Sudha Agarwal
Journal:  Antioxid Redox Signal       Date:  2013-08-12       Impact factor: 8.401

8.  Postnatal β-catenin deletion from Dmp1-expressing osteocytes/osteoblasts reduces structural adaptation to loading, but not periosteal load-induced bone formation.

Authors:  Kyung Shin Kang; Jung Min Hong; Alexander G Robling
Journal:  Bone       Date:  2016-04-30       Impact factor: 4.398

9.  Rest intervals reduce the number of loading bouts required to enhance bone formation.

Authors:  Sundar Srinivasan; Brandon J Ausk; Steven D Bain; Edith M Gardiner; Ronald Y Kwon; Ted S Gross
Journal:  Med Sci Sports Exerc       Date:  2015-05       Impact factor: 5.411

10.  Cortical and trabecular bone adaptation to incremental load magnitudes using the mouse tibial axial compression loading model.

Authors:  Alyssa M Weatherholt; Robyn K Fuchs; Stuart J Warden
Journal:  Bone       Date:  2012-10-27       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.